Colour discrimination impairment is not a reliable early marker of Parkinson's disease

Journal of Neurology

Volumn 248, Issue 11, 2001, Pages 975-978

  Veselá, Olga ^a   Růžička, Evžen ^a   Jech, Robert ^a   Roth, Jan ^a   Štěpánková, Kateřina ^a   Mečíř, Petr ^a   Solano, Zuzana ^a   Preclíková, Eva ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

100 hue test; Colour visual discrimination; Early diagnosis; Parkinson's disease

Indexed keywords

ACUTE DISEASE; ADULT; AGED; ARTICLE; CALCULATION; CLINICAL ARTICLE; COLOR; COLOR DISCRIMINATION; COLOR VISION TEST; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE DURATION; DISEASE MARKER; FEMALE; HUMAN; ILLUMINATION; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; SCORING SYSTEM; TASK PERFORMANCE; VISUAL DISORDER; VISUAL STIMULATION;

ADULT; AGED; BIOLOGICAL MARKERS; COLOR PERCEPTION; COLOR PERCEPTION TESTS; DIAGNOSIS, DIFFERENTIAL; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 0035788654     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150170051     Document Type: Article

References (14)

1. Büttner T, Kuhn W, Patzold T, Przuntek H (1994) L-Dopa improves colour vision in Parkinson's disease. J Neural Transm Park Dis Dement Sect 7:13-19
2. Büttner T, Kuhn W, Müller T, Mc Monagle U, Przuntek H (1995) Pharmacological effects of dopaminergics and amantadine on color discrimination in Parkinson's disease. Neuro-ophthalmology 15:135-141
3. Büttner T, Kuhn W, Müller Th, Patzold T, Heidbrink K, Przuntek H (1995) Distorted color discrimination in "de novo" parkinsonian patients. Neurology 45:386-387
4. Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI (1992) Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 55:138-142
5. Farnsworth D (undated) The Farnsworth 100 Hue Test for the Examination of Color Discrimination Instruction Manual. Luneau Ophtalmologie, Paris
6. Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51: 745-752
7. Koller WC (1992) When does Parkinson's disease begin? Neurology 42(Suppl 4):27-31; 41-48
8. Masson G, Mestre D, Blin O (1993) Dopaminergic modulation of visual sensitivity in man. Fundam Clin Pharmacol 7:449-463
9. Morrish PK, Sawle GV, Brooks DJ (1996) An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease. Brain 119:585-591.
10. Müller T, Kuhn W, Büttner T, Eising E, Coenen H, Haas M, Przuntek H (1998) Color vision abnormalities do not correlate with dopaminergic nigrostriatal degeneration in Parkinson's disease. J Neurol 245:659-664
11. Nguyen-Legros J (1988) Functional neuroarchitecture of the retina: hypothesis on the dysfunction of retinal dopaminergic circuitry in Parkinson's disease. Surg Radiol Anat 10:137-144
12. Price MJ, Feldman RG, Adelberg D, Kayne H (1992) Abnormalities in color vision and contrast sensitivity in Parkinson's disease. Neurology 42:887-890
13. Regan BC, Freudenthaler N, Kolle R, Mollon JD, Paulus W (1998). Colour discrimination thresholds in Parkinson's disease: results obtained with a rapid computer-controlled colour vision test. Vision Res 38:3427-3431
14. Smith VC, Pokorny J, Pass AS (1985) Color-axis determination on the Farnsworth Munsell 100-Hue test. Am J Ophthalmol 100:176-182